Molecular Biologist.

2 weeks ago


Richmond North Yorkshire, United Kingdom Touchlight Full time

Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need for a better quality, faster and more robust DNA manufacturing technology.
Our CDMO and technology is built on the conviction that DNA is fundamental to the future of medicine.

By moving away from today's restrictive biological approaches, we have made DNA manufacturing simple. Our unique dbDNA™ (or "doggybone" DNA) vector is optimised for use in advanced genetic medicines, being safer and more efficacious than conventional plasmid DNA. The platform, based on enzymatic technology, enables DNA production at unprecedented scale, speed and purity.

We are leveraging our platform to enable the next generation of Genetic Medicines. Nucleic Acid Medicines (mRNA & DNA)
ex-vivo & in-vivo cell and genetic medicines
Gene therapy using viral vectors and gene editing
Autologous & Allogenic cell therapy

Touchlight is currently seeking an experienced Scientist to join its Molecular Biology Team to genetically engineer the DNA starting material for dbDNA™ .

In addition to working at the forefront of DNA research in a dynamic biotech company , the successful candidate will receive a competitive salary, a performance related bonus, and be eligible to join the company pension scheme.

Your principal role will be to genetically engineer plasmid DNA starting material using creative and effective strategies that sits in line with clients’ needs but also allowing the best attributes of the downstream process to be harnessed.

A MSc level qualification in molecular biology or equivalent.
Practical experience in cloning DNA including: generating own strategies , creating theoretical sequence maps , primer design, PCR , bacterial transformation , and amplification.
Applicants should be well-versed in gel electrophoresis apparatus for DNA analysis and software for sequence analysis. Knowledge of running restriction digests, agarose gels and analyzing data is a must.
Familiarity with industry quality standards such as ISO/ cGMP is desirable. Experience working within a Good Manufacturing Practice (cGMP) or Good Laboratory Practice (GLP) environment is highly advantageous.

We make Touchlight an extraordinary place to work by providing our employees with incredible facilities, flexible working and a competitive benefits and remuneration package.

We believe diversity drives innovation and for that reason we strongly encourage those from all backgrounds to apply for roles at Touchlight. We are an equal opportunity employer and aim to build a workforce that is truly representative of the communities in which we operate and our customers.


  • Molecular Biologist

    2 weeks ago


    Richmond, North Yorkshire, United Kingdom Touchlight Full time

    Touchlight is focussed on the enzymatic synthesis of novel DNA formats. Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need...

  • Molecular Biologist

    Found in: Jooble UK C2 - 2 weeks ago


    Richmond, North Yorkshire, United Kingdom Touchlight Full time

    Touchlight is focussed on the enzymatic synthesis of novel DNA formats. Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need...

  • Molecular Biologist

    Found in: Appcast UK C C2 - 1 week ago


    Richmond, United Kingdom Touchlight Full time

    Touchlight is focussed on the enzymatic synthesis of novel DNA formats. Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need...

  • Molecular Biologist

    Found in: Appcast UK C2 - 1 week ago


    Richmond, United Kingdom Touchlight Full time

    Touchlight is focussed on the enzymatic synthesis of novel DNA formats. Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need...

  • Molecular Biologist

    Found in: Whatjobs ES C2 - 6 days ago


    Richmond, United Kingdom Touchlight Full time

    Touchlight is focussed on the enzymatic synthesis of novel DNA formats. Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need...

  • Molecular Biologist

    Found in: Appcast Linkedin GBL C2 - 2 weeks ago


    Richmond, United Kingdom Touchlight Full time

    Touchlight is focussed on the enzymatic synthesis of novel DNA formats. Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need...

  • Molecular Biologist

    Found in: Talent UK 2A C2 - 2 weeks ago


    Richmond, United Kingdom Touchlight Full time

    Touchlight is focussed on the enzymatic synthesis of novel DNA formats. Through the Covid pandemic, this quiet revolution has been propelled into the spotlight with the scale-up and proof of concept of RNA and DNA based vaccines. In addition, the stellar growth in viral and non-viral cell and gene therapy discovery and development has accelerated the need...